XML 40 R27.htm IDEA: XBRL DOCUMENT v3.23.3
Disposition of Subsidiary
6 Months Ended
Sep. 30, 2023
Disposition of Subsidiary Abstract  
Disposition of Subsidiary

17. Disposition of Subsidiary

Disposition of Lemonaid Health Limited

 

On August 1, 2023, the Company completed the sale of Lemonaid Health Limited, its wholly-owned, indirect U.K. subsidiary. Lemonaid Health Limited was not a significant subsidiary, and the disposition of Lemonaid Health Limited did not constitute a strategic shift that would have a major effect on the Company’s operations or financial results. As a result, the results of operations for Lemonaid Health Limited were not reported as discontinued operations under the guidance of ASC 205 “Presentation of Financial Statements.” During the three and six months ended September 30, 2023, the Company recorded $2.1 million and $2.4 million, respectively, of loss on the disposition of Lemonaid Health Limited and transaction-related costs within general and administrative expenses. The Company does not expect to incur any further material expenses in connection with the disposition.